To evaluate the diagnostic ability of plasma AAT, RAB2B, and IGFBP2 in combination with CA19-9 for pancreatic cancer, ROC curves of the 4 indicators were calculated for determining their individual and combined values in diagnosis. This evidence concerns the gene IGFBP2 and pancreatic neoplasm.